Assessing the potential for drug–drug interactions in an accelerated throughput mode
- 1 March 1999
- journal article
- Published by Elsevier in Pharmaceutical Science & Technology Today
- Vol. 2 (3), 119-120
- https://doi.org/10.1016/s1461-5347(99)00127-3
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Validation of a rapid microtiter plate assay to conduct cytochrome P450 2D6 enzyme inhibition studiesDrug Discovery Today, 1998
- Life-Threatening Interaction of Mibefradil and β-Blockers With Dihydropyridine Calcium Channel BlockersJAMA, 1998
- Evaluation of Atypical Cytochrome P450 Kinetics with Two-Substrate Models: Evidence That Multiple Substrates Can Simultaneously Bind to Cytochrome P450 Active SitesBiochemistry, 1998
- Microtiter Plate Assays for Inhibition of Human, Drug-Metabolizing Cytochromes P450Analytical Biochemistry, 1997
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Measurement of Liver Microsomal Cytochrome P450 (CYP2D6) Activity Using [O-methyl-14C] DextromethorphanAnalytical Biochemistry, 1994